David Chiswell, chairman of the UK antibody therapeutics company Kymab Ltd, has assumed the position of chief executive officer following the resignation of CEO Christian Grøndahl. Dr Chiswell will remain in the position until a permanent CEO is appointed.
Kymab announced the management change on 9 February 2015.
Copyright 2015 Evernow Publishing Ltd